Guidelines: Difference between revisions

From UrologySchool.com
Jump to navigation Jump to search
No edit summary
Line 5: Line 5:
==== Prostate ====
==== Prostate ====


* Advanced Prostate Cancer (2020)
* [[Advanced Prostate Cancer (2020)]]
* Adjuvant and Salvage Radiotherapy After Prostatectomy (2019)
* Adjuvant and Salvage Radiotherapy After Prostatectomy (2019)
* Prostate Cancer Screening (2018)
* Prostate Cancer Screening (2018)

Revision as of 15:39, 10 December 2021

AUA

Oncology

Prostate

  • Advanced Prostate Cancer (2020)
  • Adjuvant and Salvage Radiotherapy After Prostatectomy (2019)
  • Prostate Cancer Screening (2018)
  • Clinically Localized Prostate Cancer (2017)

Bladder

  • Microscopic Hematuria (2020)
  • Muscle-invasive Bladder Cancer (2017)
  • Non-muscle Invasive Bladder Cancer (2016)

Kidney

  • Renal Mass and Localized Renal Cancer (2021)

Testicular

  • (2019) Included in Testicular Tumours Chapter Notes

Non-oncology

Andrology

  • Testosterone Deficiency (2018)
  • Erectile Dysfunction (2018)
  • Peyronie's Disease (2015)

Functional

  • Surgical Management BPH (2018)
  • AUA/CUA Mesh Position Statement (2019)
  • Incontinence after Prostate Therapy (2019)
  • Female SUI (2017)

Infections and Inflammation

  • AUA/CUA Recurrent UTI (2019)
  • Pediatrics Vesicoureteral Reflux (2017)

Stones

  • Evaluation and Medical Management of Stones (2019)
  • Stone Surgery (2016)

Other

  • Urotrauma (2020)
  • Male Urethral Stricture (2016)
  • Vasectomy (2015)

Contribute

  • BPH (2021)
  • Infertility (2021)
  • Priapism (2021)
  • OAB (2019)
  • Antibiotic Prophylaxis (2019)

CUA

Oncology

Prostate

  • Castrate-resistant Prostate Cancer (2021)
  • Androgen Deprivation Therapy: Adverse Events & Management (2021)
  • Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)
  • Testosterone Suppression (2018)
  • Prostate Cancer Screening (2017)
  • Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017)
  • Prostate Cancer Active Surveillance (2015)

Bladder

  • Non-muscle Invasive Bladder Cancer (2021)
  • Advanced and Metastatic Urothelial Cancer (2019)
  • Muscle-invasive Bladder Cancer (2019)
  • Asymptomatic Mircoscopic Hematuria (2008)

Kidney

  • Follow-up Localized RCC (2018)
  • Cystic Renal Lesions (2017)
  • Small Renal Masses (2015)
  • Surgical Management of RCC (2014)
  • RCC Genetic Screening (2013)

Non-oncology

Andrology

  • Peyronie's Disease (2018)
  • Erectile Dysfunction (2021)

Functional

  • Neurogenic Lower Urinary Tract Dysfunction (2019)
  • Male LUTS/BPH (2018)
  • CUA/AUA Mesh Position Statement (2019)
  • Overactive Bladder (2017)

Infections and Inflammation

  • CUA/AUA Recurrent UTI (2019)
  • Antibiotic Prophylaxis (2015)
  • Chronic Scrotal Pain (2018)
  • Interstitial Cystitis (2016)

Infertility

  • Azoospermia (2015)

Pediatrics

  • Circumcision (2018)
  • Antenatal hydronephrosis (2017)
  • Cryptorchidism (2017)
  • Multicystic Dysplastic Kidney in the Neonate (2015)

Stones

  • Evaluation and Medical Management of Stones (2016)
  • Ureteral Calculi (2015)

Other

  • Vasectomy (2016)
  • Adrenal Mass (2011)
  • Radiation-induced Hemorrhagic Cystitis (2018)
  • VTE Prophylaxis (2019)

Contribute

  • Ureteral calculi (2022)
  • Pediatric bladder dysfunction (2021)
  • Sporadic angiomyolipomas (2020)
  • Male urethral stricture (2020)
  • Catheter use (2020)
  • Renal mass biopsy (2019)
  • Pheochromocytoma surveillance (2019)
  • Pediatric hemorrhagic cystitis (2019)